Royalty Pharma plc ( RPRX) Dividends
Last dividend for Royalty Pharma plc (RPRX) as of May 18, 2025 is 0.22 USD. The forward dividend yield for RPRX as of May 18, 2025 is 2.59%. Average dividend growth rate for stock Royalty Pharma plc (RPRX) for past three years is 8.65%.
Dividend history for stock RPRX (Royalty Pharma plc) including historic stock price, dividend growth rate predictions based on history and split, spin-off and special dividends.
Royalty Pharma plc Dividends
| Ex-dividend date | Payable date | Dividend amount (change) | Adjusted Price | Close Price |
|---|---|---|---|---|
| 2025-05-16 | 2025-06-10 | 0.2200 USD | Upcoming dividend | |
| 2025-02-21 | 2025-03-10 | 0.2200 USD (4.76%) | 30.39 USD | 30.39 USD |
| 2024-11-15 | 2024-12-10 | 0.2100 USD | 27.98 USD | 27.98 USD |
| 2024-08-16 | 2024-09-13 | 0.2100 USD | 28.14 USD | 28.14 USD |
| 2024-05-16 | 2024-06-14 | 0.2100 USD | 28.16 USD | 28.16 USD |
| 2024-02-15 | 2024-03-15 | 0.2100 USD (5%) | 29.03 USD | 29.03 USD |
| 2023-11-16 | 2023-12-15 | 0.2000 USD | 26.72 USD | 26.72 USD |
| 2023-08-17 | 2023-09-15 | 0.2000 USD | 31.19 USD | 31.19 USD |
| 2023-05-18 | 2023-06-15 | 0.2000 USD | 33.75 USD | 33.75 USD |
| 2023-02-15 | 2023-03-15 | 0.2000 USD (5.26%) | - | - |
| 2022-11-17 | 2022-12-15 | 0.1900 USD | 42.33 USD | 42.33 USD |
| 2022-08-18 | 2022-09-15 | 0.1900 USD | 43.97 USD | 44.17 USD |
| 2022-05-19 | 2022-06-15 | 0.1900 USD | 39.43 USD | 39.78 USD |
| 2022-02-17 | 2022-03-15 | 0.1900 USD (11.76%) | 39.15 USD | 39.68 USD |
| 2021-11-18 | 2021-12-15 | 0.1700 USD | 41.23 USD | 41.98 USD |
| 2021-08-19 | 2021-09-15 | 0.1700 USD | 38.03 USD | 38.88 USD |
| 2021-05-19 | 2021-06-15 | 0.1700 USD | 38.96 USD | 40.01 USD |
| 2021-02-18 | 2021-03-15 | 0.1700 USD (13.33%) | 45.09 USD | 46.49 USD |
| 2020-11-19 | 2020-12-15 | 0.1500 USD | 40.08 USD | 41.48 USD |
| 2020-09-14 | 2020-09-30 | 0.1500 USD | 38.34 USD | 39.82 USD |
RPRX
List: Challengers
Price: $34.02
Dividend Yield: 2.68%
Forward Dividend Yield: 2.59%
Payout Ratio: 56.00%
Dividend Per Share: 0.88 USD
Earnings Per Share: 2.45 USD
P/E Ratio: 13.18
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Ebitda: -16.0 millionMarket Capitalization: 18.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 6
DGR3: 8.65%